Genetic vaccination against experimental infection with myotropic parasite strains of Trypanosoma cruzi.
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/8155 |
Resumo: | Escola Paulista de Medicina - UNIFESP. Centro de Terapia Celular e Molecular - CTCMol. São Paulo, SP, Brasil / Universidade Federal de São Paulo. Escola Paulista de Medicina. Departmento de Microbiologia, Imunologia e Parasitologia. São Paulo, SP, Brasil |
id |
CRUZ_9ac6ccf856c83cd6ba9d35e5352a2933 |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/8155 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Araujo, Adriano Fernando da SilvaOliveira, Gabriel deVasconcelos, Juliana FragaErsching, JonatanDominguez, Mariana RibeiroVasconcelos, José Ronnie Carvalho deMachado, Alexandre VieiraGazzinelli, Ricardo TostesRomero, Oscar BrunaSoares, Milena Botelho PereiraRodrigues, Maurício Martins2014-08-08T17:51:54Z2014-08-08T17:51:54Z2014ARAÚJO, Adriano Fernando da Silva et al. Genetic vaccination against experimental infection with myotropic parasite strains of Trypanosoma cruzi. Mediators of Inflammation, 2014, p. 605023, 2014.1466-1861https://www.arca.fiocruz.br/handle/icict/815510.1155/2014/605023engHindawi Publishing CorporationTrypanosoma cruziDoença de ChagasVacinaçãoAnimaisCamundongosPatologiaGenetic vaccination against experimental infection with myotropic parasite strains of Trypanosoma cruzi.info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleEscola Paulista de Medicina - UNIFESP. Centro de Terapia Celular e Molecular - CTCMol. São Paulo, SP, Brasil / Universidade Federal de São Paulo. Escola Paulista de Medicina. Departmento de Microbiologia, Imunologia e Parasitologia. São Paulo, SP, BrasilFundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório Biologia Celular. Rio de Janeiro, RJ, BrasilFundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Salvador, BA, Brasil / Hospital São Rafael. Salvador, BA, BrasilEscola Paulista de Medicina - UNIFESP. Centro de Terapia Celular e Molecular - CTCMol. São Paulo, SP, Brasil / Universidade Federal de São Paulo. Escola Paulista de Medicina. Departmento de Microbiologia, Imunologia e Parasitologia. São Paulo, SP, BrasilEscola Paulista de Medicina - UNIFESP. Centro de Terapia Celular e Molecular - CTCMol. São Paulo, SP, Brasil / Universidade Federal de São Paulo. Escola Paulista de Medicina. Departmento de Microbiologia, Imunologia e Parasitologia. São Paulo, SP, BrasilEscola Paulista de Medicina - UNIFESP. Centro de Terapia Celular e Molecular - CTCMol. São Paulo, SP, Brasil / Universidade Federal de São Paulo. Escola Paulista de Medicina. Departmento de Microbiologia, Imunologia e Parasitologia. São Paulo, SP, Brasil / Departamento de Biociências. Instituto de Saúde e Sociedade - UNIFESP. Santos, SP, BrazilFundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, MG, BrasilFundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, MG, Brasil / Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Departamento de Bioquímica e Imunologia. Belo Horizonte, BH, Brasil / University of Massachusetts Medical School. Division of Infectious Disease and Immunology. Department of Medicine. Worcester, MA, USAUniversidade Federal de Santa Catarina. Departamento de Microbiologia, Imunologia e Parasitologia. Florianopolis, SC, BrasilFundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Salvador, BA, Brasil / Hospital São Rafael. Salvador, BA, BrasilEscola Paulista de Medicina - UNIFESP. Centro de Terapia Celular e Molecular - CTCMol. São Paulo, SP, Brasil / Universidade Federal de São Paulo. Escola Paulista de Medicina. Departmento de Microbiologia, Imunologia e Parasitologia. São Paulo, SP, BrasilIn earlier studies, we reported that a heterologous prime-boost regimen using recombinant plasmid DNA followed by replicationdefective adenovirus vector, both containing Trypanosoma cruzi genes encoding trans-sialidase (TS) and amastigote surface protein (ASP) 2, provided protective immunity against experimental infection with a reticulotropic strain of this human protozoan parasite. Herein, we tested the outcome of genetic vaccination of F1 (CB10XBALB/c) mice challenged withmyotropic parasite strains (Brazil and Colombian). Initially, we determined that the coadministration during priming of a DNA plasmid containing themurine IL-12 gene improved the immune response and was essential for protective immunity elicited by the heterologous prime-boost regimen in susceptiblemale mice against acute lethal infections with these parasites. The prophylactic or therapeutic vaccination of resistant female mice led to a drastic reduction in the number of inflammatory infiltrates in cardiac and skeletal muscles during the chronic phase of infection with either strain. Analysis of the electrocardiographic parameters showed that prophylactic vaccination reduced the frequencies of sinus arrhythmia and atrioventricular block. Our results confirmed that prophylactic vaccination using the TS and ASP-2 genes benefits the host against acute and chronic pathologies caused by T. cruzi and should be further evaluated for the development of a veterinary or human vaccine against Chagas disease.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZORIGINALAraujo A F Genetic vaccination....pdfAraujo A F Genetic vaccination....pdfapplication/pdf1985863https://www.arca.fiocruz.br/bitstream/icict/8155/1/Araujo%20A%20F%20Genetic%20vaccination....pdf152a600e90eae679adc9f1fbbda2d1f7MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81914https://www.arca.fiocruz.br/bitstream/icict/8155/2/license.txt7d48279ffeed55da8dfe2f8e81f3b81fMD52TEXTAraujo A F Genetic vaccination....pdf.txtAraujo A F Genetic vaccination....pdf.txtExtracted texttext/plain49860https://www.arca.fiocruz.br/bitstream/icict/8155/3/Araujo%20A%20F%20Genetic%20vaccination....pdf.txtdd8c7c3345a8b7e1cf8ac0d369d98a8fMD53icict/81552023-09-14 16:02:21.359oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-09-14T19:02:21Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Genetic vaccination against experimental infection with myotropic parasite strains of Trypanosoma cruzi. |
title |
Genetic vaccination against experimental infection with myotropic parasite strains of Trypanosoma cruzi. |
spellingShingle |
Genetic vaccination against experimental infection with myotropic parasite strains of Trypanosoma cruzi. Araujo, Adriano Fernando da Silva Trypanosoma cruzi Doença de Chagas Vacinação Animais Camundongos Patologia |
title_short |
Genetic vaccination against experimental infection with myotropic parasite strains of Trypanosoma cruzi. |
title_full |
Genetic vaccination against experimental infection with myotropic parasite strains of Trypanosoma cruzi. |
title_fullStr |
Genetic vaccination against experimental infection with myotropic parasite strains of Trypanosoma cruzi. |
title_full_unstemmed |
Genetic vaccination against experimental infection with myotropic parasite strains of Trypanosoma cruzi. |
title_sort |
Genetic vaccination against experimental infection with myotropic parasite strains of Trypanosoma cruzi. |
author |
Araujo, Adriano Fernando da Silva |
author_facet |
Araujo, Adriano Fernando da Silva Oliveira, Gabriel de Vasconcelos, Juliana Fraga Ersching, Jonatan Dominguez, Mariana Ribeiro Vasconcelos, José Ronnie Carvalho de Machado, Alexandre Vieira Gazzinelli, Ricardo Tostes Romero, Oscar Bruna Soares, Milena Botelho Pereira Rodrigues, Maurício Martins |
author_role |
author |
author2 |
Oliveira, Gabriel de Vasconcelos, Juliana Fraga Ersching, Jonatan Dominguez, Mariana Ribeiro Vasconcelos, José Ronnie Carvalho de Machado, Alexandre Vieira Gazzinelli, Ricardo Tostes Romero, Oscar Bruna Soares, Milena Botelho Pereira Rodrigues, Maurício Martins |
author2_role |
author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Araujo, Adriano Fernando da Silva Oliveira, Gabriel de Vasconcelos, Juliana Fraga Ersching, Jonatan Dominguez, Mariana Ribeiro Vasconcelos, José Ronnie Carvalho de Machado, Alexandre Vieira Gazzinelli, Ricardo Tostes Romero, Oscar Bruna Soares, Milena Botelho Pereira Rodrigues, Maurício Martins |
dc.subject.other.pt_BR.fl_str_mv |
Trypanosoma cruzi Doença de Chagas Vacinação Animais Camundongos Patologia |
topic |
Trypanosoma cruzi Doença de Chagas Vacinação Animais Camundongos Patologia |
description |
Escola Paulista de Medicina - UNIFESP. Centro de Terapia Celular e Molecular - CTCMol. São Paulo, SP, Brasil / Universidade Federal de São Paulo. Escola Paulista de Medicina. Departmento de Microbiologia, Imunologia e Parasitologia. São Paulo, SP, Brasil |
publishDate |
2014 |
dc.date.accessioned.fl_str_mv |
2014-08-08T17:51:54Z |
dc.date.available.fl_str_mv |
2014-08-08T17:51:54Z |
dc.date.issued.fl_str_mv |
2014 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
ARAÚJO, Adriano Fernando da Silva et al. Genetic vaccination against experimental infection with myotropic parasite strains of Trypanosoma cruzi. Mediators of Inflammation, 2014, p. 605023, 2014. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/8155 |
dc.identifier.issn.none.fl_str_mv |
1466-1861 |
dc.identifier.doi.none.fl_str_mv |
10.1155/2014/605023 |
identifier_str_mv |
ARAÚJO, Adriano Fernando da Silva et al. Genetic vaccination against experimental infection with myotropic parasite strains of Trypanosoma cruzi. Mediators of Inflammation, 2014, p. 605023, 2014. 1466-1861 10.1155/2014/605023 |
url |
https://www.arca.fiocruz.br/handle/icict/8155 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Hindawi Publishing Corporation |
publisher.none.fl_str_mv |
Hindawi Publishing Corporation |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/8155/1/Araujo%20A%20F%20Genetic%20vaccination....pdf https://www.arca.fiocruz.br/bitstream/icict/8155/2/license.txt https://www.arca.fiocruz.br/bitstream/icict/8155/3/Araujo%20A%20F%20Genetic%20vaccination....pdf.txt |
bitstream.checksum.fl_str_mv |
152a600e90eae679adc9f1fbbda2d1f7 7d48279ffeed55da8dfe2f8e81f3b81f dd8c7c3345a8b7e1cf8ac0d369d98a8f |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813008836795039744 |